922 related articles for article (PubMed ID: 33436044)
1. Targeting hypoxic tumor microenvironment in pancreatic cancer.
Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
[TBL] [Abstract][Full Text] [Related]
2. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia: a barricade to conquer the pancreatic cancer.
Tan Z; Xu J; Zhang B; Shi S; Yu X; Liang C
Cell Mol Life Sci; 2020 Aug; 77(16):3077-3083. PubMed ID: 31907561
[TBL] [Abstract][Full Text] [Related]
4. The role of hypoxia in pancreatic cancer: a potential therapeutic target?
Erkan M; Kurtoglu M; Kleeff J
Expert Rev Gastroenterol Hepatol; 2016; 10(3):301-16. PubMed ID: 26560854
[TBL] [Abstract][Full Text] [Related]
5. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
[TBL] [Abstract][Full Text] [Related]
6. Matrix control of pancreatic cancer: New insights into fibronectin signaling.
Topalovski M; Brekken RA
Cancer Lett; 2016 Oct; 381(1):252-8. PubMed ID: 26742464
[TBL] [Abstract][Full Text] [Related]
7. Cytokine network: new targeted therapy for pancreatic cancer.
Matsuo Y; Takeyama H; Guha S
Curr Pharm Des; 2012; 18(17):2416-9. PubMed ID: 22372505
[TBL] [Abstract][Full Text] [Related]
8. Fucoidan-Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Co-Targeting Tumor Hypoxia and Angiogenesis.
Shin SW; Jung W; Choi C; Kim SY; Son A; Kim H; Lee N; Park HC
Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30558324
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma.
Kim MC; Hwang SH; Kim NY; Lee HS; Ji S; Yang Y; Kim Y
BMC Cancer; 2018 Aug; 18(1):819. PubMed ID: 30111297
[TBL] [Abstract][Full Text] [Related]
10. Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.
Li X; Ma Q; Xu Q; Duan W; Lei J; Wu E
Curr Pharm Des; 2012; 18(17):2404-15. PubMed ID: 22372501
[TBL] [Abstract][Full Text] [Related]
11. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more.
Hao X; Ren Y; Feng M; Wang Q; Wang Y
Biomed Pharmacother; 2021 Sep; 141():111798. PubMed ID: 34120068
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia induces TWIST-activated epithelial-mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice.
Chen S; Chen JZ; Zhang JQ; Chen HX; Yan ML; Huang L; Tian YF; Chen YL; Wang YD
Cancer Lett; 2016 Dec; 383(1):73-84. PubMed ID: 27693633
[TBL] [Abstract][Full Text] [Related]
14. Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters.
Dauer P; Nomura A; Saluja A; Banerjee S
Pancreatology; 2017; 17(1):7-12. PubMed ID: 28034553
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
Li W; Cao L; Chen X; Lei J; Ma Q
Oncol Rep; 2016 Mar; 35(3):1718-26. PubMed ID: 26707376
[TBL] [Abstract][Full Text] [Related]
16. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells.
Russi S; Verma HK; Laurino S; Mazzone P; Storto G; Nardelli A; Zoppoli P; Calice G; La Rocca F; Sgambato A; Lucci V; Falco G; Ruggieri V
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370155
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment participates in metastasis of pancreatic cancer.
Ren B; Cui M; Yang G; Wang H; Feng M; You L; Zhao Y
Mol Cancer; 2018 Jul; 17(1):108. PubMed ID: 30060755
[TBL] [Abstract][Full Text] [Related]
18. Enhancing the chemotherapy effect of Apatinib on gastric cancer by co-treating with salidroside to reprogram the tumor hypoxia micro-environment and induce cell apoptosis.
Zhang Z; Yang W; Ma F; Ma Q; Zhang B; Zhang Y; Liu Y; Liu H; Hua Y
Drug Deliv; 2020 Dec; 27(1):691-702. PubMed ID: 32397840
[TBL] [Abstract][Full Text] [Related]
19. Advanced nanotechnology for hypoxia-associated antitumor therapy.
Zhao L; Fu C; Tan L; Li T; Zhong H; Meng X
Nanoscale; 2020 Feb; 12(5):2855-2874. PubMed ID: 31965135
[TBL] [Abstract][Full Text] [Related]
20. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
